Virtus LifeSci Valuation Overview

BBP -- USA Etf  

USD 45.29  0.88  1.91%

Virtus LifeSci Biotech has current Real Value of $46.25 per share. The regular price of the etf is $45.29. At this time the etf appears to be under valued. Macroaxis measures value of Virtus LifeSci Biotech from inspecting the etf fundamentals such as Number of Employees of 12, Net Asset of 32.55M and Price to Earning of 18.03times as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securities prices and their ongoing real values will draw towards each other.
 Time Horizon     30 Days    Login   to change
Virtus LifeSci Biotech Products ETF is the top ETF in price to book as compared to similar ETFs. It is the top ETF in equity positions weight as compared to similar ETFs making about  60.21  of Equity Positions Weight per Price to Book.

Current Market Valuation

Virtus LifeSci Biotech Valuation Boundaries
Under Valued
June 21, 2018
Market Value
Real Value
Target Odds
Virtus LifeSci is not too risky asset. Calculation of real value of Virtus LifeSci Biotech is based on 1 month time horizon. Increasing Virtus LifeSci Biotech time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Net Asset

Virtus LifeSci Net Asset Analysis
Virtus LifeSci Biotech Products ETF is the top ETF in net asset as compared to similar ETFs. Total Asset Under Management (AUM) of Health category is currently estimated at about 751.81 Billion. Virtus LifeSci adds roughly 32.55 Million in net asset claiming only tiny portion of all ETFs under Health category.
Check also Trending Equities. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.